Akinlo, Ambrose, Adeleke Bisiriyu, and Olapeju Esimai
1
Al Moosawi, S.
1
Alice Mark
1
Aliku, T. et al.
1
Alipanah N, Jarlsberg L et al.
1
Allach, Y.
1
Alvarado R., Ramírez J. et al
1
Alves, C.
1
Amini, M.
1
Anaya-Covarrubias, J.Y.
1
and J. Garcia-Rosales Delgado
1
Armstrong, G.
1
Aye Kyawt Paing et al.
1
B. Ezenwa
1
B.S. Kamps
1
Banerjee, A.
1
Bapoutou, B.
1
Bazargani, Y.T.
1
Bălă, G.P.
1
Begum, T. S. M.
1
Bennett, James et al.
1
Berry, P.
1
Betrò, S.
1
BMC
1
BMC Cardiovascular Disorders
1
BMC Infectious Diseases
1
BMJ Open
1
Bo Peng , Rowland W. Pettit, and Christopher I. Amos
1
Bo Wen, Rongbin Xu, Yao Wu, Micheline de Sousa Zanotti Stagliorio Coelho et al.
1
Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, Burford, Gemma, Shein, Kin. et al. (2005). WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japa
1
Bozorgmehr, K.
1
Braae, U.
1
Breitner-Busch, S.
1
Bundeszentrale für gesundheitliche Aufklärung
1
C. C. Onyedum, I. Alobu, K. N. Ukwaja
1
C. Contini, M. Maritari, M. die Nuzzo, et al.
1
C. Hoffmann, A. Gualani Gualani
1
C. Hoffmann, et al.
1
C. Hughes
1
C. Wilcox, L. Lebreton et al.
1
Cadernos de Saúde Pública
1
Camp, R. and C. Hoffmann
1
Cancer Association of South Africa (CANSA)
1
Cawthrope, D.
1
Center for Global Development
1
Central Research Institute of Epidemiology of Rospotrebnadzor
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Chambliss, S. E.
1
Charles B. Nemeroff
1
Chaziya J, Freyne B, Lissauer S et al.
1
China CDC Weekly, CCDC Weekly
1
Chou-Zen Giam
1
Chu, D.K.
1
Cianconi, P.
1
Circulation
1
CMAM Forum
1
Cogent Medicine
1
Cole CP, James PB, Kargbo AT
1
College of American Pathologists
1
Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL)
1
Convention on Biological Diversity
1
D. Gyamfi Amoako, R. Carrel Founou, et al.
1
D. Kerrigan
1
D. Luo
1
Dai, W., Kaminga, A.C., Tan, H., Wang, J., Lai, Z., Wu, X., Xiong, Y., Deng, J. & Liu, A.
1
DeFilipps, Robert A.
1
Department of Health Research Ministry of Health & Family Welfare
1
Desogus, A.
1
Deutsche Hauptstelle für Suchtfragen e.V.
1
Dèdonougbo Houenassi, M.
1
Dhan Bahadur Shrestha, Pravash Budhathoki, Bipana Gurung et al.
1
Dheda, K.
1
Doyle, M.P.
1
Dr. A. Wang
1
Dr. E. Emmett
1
E van‘t Hof, P Cuijpers, W Waheed, DJ Stein
1
E. Stevens
1
E.A Akl, S. Duda, et al.
1
Eckstein, D.
1
Ejembi, Clara Ladi, Tukur Dahiru, and Alhaji A. Aliyu
1
END TBc1
1
Environmental Science and Pollution Research
1
Espira, L. M.
1
Etienne V Langlois, Andrew Mc Kenzie, Helen Schneider & Jeffrey W Mecaskey
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for Disease Prevention and Control ECDC
1
European Centre for Disease Prevention and Control (ECDC)
1
European Respiratory Journal, part of the European Respiratory Society (ERS)
1
Evangelina IN, Inês T, Miguelhete L et al
1
F. Zermoglio
1
Fajolu, I.
1
Ferres M., Potin M.
1
Fitzgerald, F.
1
Florian Lederbogen, Leila Haddad, Andreas Meyer-Lindenberg
1
Flying Publisher, Boehringer Ingelheim
1
Food and Agriculture Organization (FAO)
1
Fooks, A.
1
Founou, L.L.
1
Freedman, B.
1
Frontiers in Cardiovascular Medicine
1
G, Zambrano, E Salgato, F. M. Moyano et al.
1
G. H. Loneragan, H. M. Scott et al.
1
G. K. Siberry
1
G. S. Bel
1
Gabrys, J.
1
GBD 2019 Blindness and Vision Impairment Collaborator
1
GBD 2019 Blindness and Vision Impairment Collaborators
1
Germanwatch e.V.
1
Gil, A.
1
Gleeson, T.
1
Glenn, B. E.
1
Global Health Journal
1
Global Heart
1
Gojka Roglic, Cherian Varghese, Leanne Riley et al.
1
Grimshaw, J. M.
1
Gulani, A. & Sachdev, H.P.S
1
Gulev S. K., Thorne P. W. et al.
1
Guo Y., , Ye T., et al.
1
H. Kuper and K. Blanchett , et al.
1
H.L. Nguyen
1
Halaharvi, H.
1
Haute Conseil de la Santé Publique
1
Health Cluster
1
Hepatology Society of the Philippines
1
Hepatology Society of the Philippines (HSP)
1
Hindricks, G.
1
Hoffmann, C.
1
Hong‑Mei Luo
1
Hsia Y., B. R Lee, A. Versporten, et al
1
Hua Yu
1
Huffman, M. et al.
1
I. J. C. Schneider
1
I. Mokrousov, (St. Petersburg Pasteur Institute)
1
I. Semini
1
iMMAP
1
Imperial College COVID-19 Response Team
1
INTECH
1
International Diabetes Federation
1
International I nitiativ e for Impact E valuation (3ie)
1
International Primary Care Respiratory Group IPCRG
1
International Union Against Tuberculosis and Lung Disease, World Health Organization
1
IOP Science
1
IPAS
1
Iris (Institutional Repository)
1
J Family Med Prim Care
1
Jackson, J., Kheng Heng, L., Eklund, G. et al.
1
JAMIA Open
1
Janiri, L.
1
Jésuites d'Afrique de l'Ouest
1
Jing, Q.
1
Journal of Health Monitoring
1
Journal of the American College of Cardiology
1
Journal of the International AIDS Society
1
Julián-Jiménez, A.
1
K. P Msyamboza, L.Mawaya 2 , H.W Kubwalo, et al.
1
K.L.Ebi
1
Kakkar M., Chatterjee P. et. al.
1
Kalafs.S.
1
Kang Yiu Lai, Wing Yiu George Ng and Fan Fanny Cheng
1
Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al.
1
Kishimoto T., Robenzadeh A, Leucht C, et al.
1
Krupnick, Gary A.
1
Kumar Roy., S. and S. Bhattacharjee
1
L. Zhou
1
L.Houétondji Codjo, D. Dokoui, S, et al.
1
Ladnaya, N.
1
Larson, M. C.
1
Larson, P. S.
1
Lee, V.
1
Leufkens, H.G.M. et al.
1
Lewis, C. Jr., Akinyi, M., DeWitte, S. et al.
1
Limeira, C.
1
Lockwod DN.
1
M. Dara, C. D. Acosta, M. V. S. Vinklers Melchers, et al.
1
M. F. Biudes
1
M. Fritzsche
1
M. G. Whitfield, H. M. Soeters, R. M. Warren, et al.
1
M. J. Abzug
1
M. Lefebvre
1
M. Mayan
1
M. Schomaker
1
M.-A. Davies
1
M.J. Nieuwenhuijsen, M. Gascon
1
Mailloux, N.A. et al.
1
Makanjuola, A. et al.
1
Makwe, C.
1
Mallick, Lindsay, Wenjuan Wang, Temsah, Gheda
1
Manas R. , Behera R., Satpathy S.K.
1
Mark, A.
1
Martinez Viciana, C.
1
Martínez-Austria Polioptro,F and Bandala E. R
1
McCaula, M.
1
McKee, M.
1
Medicine
1
Mensah, G.A.
1
Mental Health and Psychosocial Support Network
1
MHPSS.net
1
Minh D Pham
1
Ministerio da Saude Brasilia
1
Ministerio de Salud Argentina
1
Ministerio de Salud Chile
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministério da Saúde, Brazil
1
Ministério da Saúde, Secretaria de Atenção Primária à Saúde Brasil
1
Minja, N.W.
1
Morse, J.M.
1
Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)
1
Mücke, H.
1
N. B Ilangaratne
1
N. N. Mannakkara
1
Nakagaayi, D.
1
Nalbandian, A.
1
National Department of Health, South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Neuron Review
1
Nkoa, F.C.
1
Nuffield Council on Bioethics
1
O. Neyrolles (Institut de Pharmacologie et de Biologoie Structurale)
1
Obago, Irene T
1
Oliveira e Souza, R.
1
OPAS, OMS
1
OPS
1
Organisation de la Santé Mondiale
1
Organisation Mondiale de la Santé (OMS)
1
Organización Mundial de la Salud (OMS)
1
Organización Mundial de Saude and OPAS
1
P. M. Enright, J. Shumake-Guillemot et al.
1
P. O. Zogo2
1
PAHO (Pan American Health Organization
1
Pan American Health Organization
1
Pan American Health Organization PAHO, World Health Organization WHO
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...method, nucleic acid amplification tests (NAATs). This interim guidance offers recommendations on the priority uses of antigen-detecting rapid diagnostic tests (Ag-RDTs) in specific populations and settings, including (i) for primary case detection in symptomatic individuals suspected to be infected and asymptomatic individuals at high risk of COVID-19, (ii) for contact tracing, (iii) during outbreak investigations and (iv) to monitor trends of disease incidence in communities. Ag-RDTs meeting minimum performance requirements can be used outside of clinical and laboratory settings, including in communities, by trained operators in accordance with instructions. The guidance additionally provides recommendations on implementation, product selection and storage.more
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...ed: version 15 March 2022.more
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...ildren. If children with mild or no symptoms transmit the disease, they may act as drivers of transmission within their communities. Understanding symptoms, infectivity and patterns of SARS-CoV-2 transmission in children and adolescents is essential for developing, adapting and improving control measures for COVID-19 across all ages. This is a summary of the current knowledge around SARS-CoV-2 infection acquisition and transmission and COVID-19 disease symptoms in children and adolescents. It aims to inform decisions, based on local contexts, on how to best keep schools, kindergarten and day-care facilities open and what advice to apply to intergenerational mixing.more
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...ests, ce qui a entraîné un nombre moins important de cas identifiés de COVID-19 chez les enfants. Si les enfants présentant des symptômes légers ou inexistants transmettent la maladie, ils peuvent agir comme des vecteurs de transmission au sein de leur communauté. Il est essentiel de comprendre les symptômes, l'infectivité et les modes de transmission du SRAS-CoV-2 chez les enfants et les adolescents pour développer, adapter et améliorer les mesures de contrôle du COVID-19 à tous les âges. Ce document est un résumé des connaissances actuelles concernant l'acquisition et la transmission de l'infection par le SRAS-CoV-2 et les symptômes de la maladie COVID-19 chez les enfants et les adolescents. Il vise à éclairer les décisions, en fonction des contextes locaux, sur la meilleure façon de maintenir ouvertes les écoles, les jardins d'enfants et les crèches et sur les conseils à appliquer en matière de mixité intergénérationnelle.more
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...is also provided to standardize monitoring and public reporting of variant circulation.
The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variantsmore
Orientations provisoires
9 août 2021
Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractér...isation et l'évaluation du risque que présentent ces variantes. k posés par ces variants. Un ensemble d'indicateurs est également fourni pour normaliser la surveillance et la déclaration publique de la circulation des variants.
Ce document est principalement destiné aux autorités de santé publique nationales et infranationales et aux partenaires qui soutiennent la mise en œuvre de la surveillance des variantes du SRAS-CoV-2.more
Временные рекомендации
9 августа 2021 г.
Цель данного документа - описать минимальный набор мероприятий по эпиднадзору, рекомендуемых на национальном уровне для вы...вления и мониторинга относительной распространенности вариантов SARS-CoV-2, и наметить набор мероприятий для характеристики и оценки риска, создаваемого этими вариантами. Также приводится набор показателей для стандартизации мониторинга и публичной отчетности о циркуляции вариантов.
Документ предназначен в первую очередь для национальных и субнациональных органов здравоохранения и партнеров, поддерживающих внедрение эпиднадзора за вариантами SARS-CoV-2.more
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa...ra la caracterización y evaluación del riesgo que plantean estas variantes. También se ofrece un conjunto de indicadores para normalizar la vigilancia y la notificación pública de la circulación de variantes.
El documento está dirigido principalmente a las autoridades de salud pública nacionales y subnacionales y a los socios que apoyan la aplicación de la vigilancia de las variantes del SRAS-CoV-2more
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés tests de diagnostic rapide, TDR) offre une méthode plus rapide et moins coûteuse pour te...ster le SRAS-CoV-2 que la méthode de référence, les tests d'amplification des acides nucléiques (TAAN). Ces lignes directrices provisoires offrent des recommandations sur les utilisations prioritaires des tests de diagnostic rapide à détection d'antigène (TDR-Ag) dans des populations et des contextes spécifiques, notamment (i) pour la détection primaire des cas chez les personnes symptomatiques suspectées d'être infectées et les personnes asymptomatiques à haut risque de COVID-19, (ii) pour la recherche des contacts, (iii) pendant les enquêtes sur les épidémies et (iv) pour surveiller les tendances de l'incidence de la maladie dans les communautés. Les TDR-AG répondant aux exigences minimales de performance peuvent être utilisés en dehors des milieux cliniques et des laboratoires, y compris dans les communautés, par des opérateurs formés conformément aux instructions. Le guide fournit en outre des recommandations sur la mise en œuvre, la sélection des produits et le stockagemore
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...thods. Oral Pre-exposure Prophylaxis (PrEP) is proven to be highly effective as an additional prevention choice for reducing the risk of HIV acquisition, including for AGYW. Successful uptake and adherence to PrEP is critical in its effectiveness as an HIV prevention method, however, the current demand for PrEP by AGYW is low with suboptimal adherence.
Within the ESA region, there is currently great impetus to address these challenges and scale up PrEP for AGYW. A critical aspect of this is to leverage the learnings and evidence from implementation of how to improve the demand and quality of PrEP programming for this population. Improving the Quality of Pre-Exposure Prophylaxis Implementation for Adolescent Girls and Young Women in Eastern and Southern Africa examines the current efforts in the region to accelerate and scale up evidence-based PrEP delivery platforms. The implementation brief provides current knowledge and builds on WHO guidance to provide key considerations for implementation, including driving demand and improving quality, as well as focus on wider combination prevention and integration agendas.more
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022